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It was recently found that high 
concentrations of chicken yolk ges-
tagens and gestagen metabolites 
hamper corticosterone quanti ca-
tion via immunoassays. However, 
the situation in chicken albumen is 
still unresolved. In addition, the ra-
tio of steroid hormone in the yolk of 
wild birds might differ. To investi-
gate these matters, corticosterone 
and gestagens were measured in 
individual fractions of high-perfor-
mance liquid-chromatographic se-
parations of chicken albumen and 
yolk of red jungle fowl. Similarly, 
yolk extracts of hens with cortico-
sterone-releasing implants or pla-
cebos were analysed to assess the 
impact of elevated plasma cortico-
sterone concentrations on authen-
tic yolk corticosterone levels. We 
also compared the results of a pre-
viously used corticosterone en-
zyme immunoassay (EIA) to those 
from a commercial radioimmuno-
assay (RIA) kit. The analytical vali-
dations of chicken albumen, banki-
va yolk and yolks from hens with or 
without arti cially elevated plasma 
corticosterone levels indicated that 
the main share of the immunoreac-
tivity measured via corticosterone 
immunoassays was caused by 






Kortikosteron im Vogelei: Die 
Wichtigkeit der analytischen 
Validierung
Einleitung
Kürzlich wurde festgestellt, dass 
Eidotter von Hennen hohe Konzen-
trationen an Gestagenen und Ges-
tagenmetaboliten enthält, welche 
die Quanti zierung von Kortiko-
steron mittels Immunoassays be-
hindern. Ob dies auch im Eiklar so 
ist, war bisher unklar. Weiters kön-
nte Eidotter von Wildvögeln ein an-
deres Verhältnis von Steroidhormo-
nen aufweisen. 
Material und Methoden
Es wurden daher Dotterproben 
von Bankivahühnern und Eiklar von 
Haushühnern nach Extraktion mit-
tels Hochleistungs-Flüssigkeits-
chromatographie getrennt und Kor-
tikosteron sowie Gestagene in den 
einzelnen Fraktionen quanti ziert. 
In gleicher Weise wurden Dotter-
proben von Hennen, die mit einem 
kortikosteronfreisetzenden Pellet 
oder einem Placebo implantiert wa-
ren, analysiert, um die Auswirkun-
gen von erhöhtem Plasmakortiko-
steronspiegel auf die Dotterkortiko-
steronkonzentration zu testen. Zu-
sätzlich verglichen wir den zuvor 
verwendeten EIA mit einem kom-
merziellen RIA Kit. 
Ergebnisse
Die analytischen Validierungen 
von Hühnereiklar, Bankivadotter 
und Dotter von Hennen mit erhöh-
ten oder nicht erhöhten Plasmakor-
tikosteronspiegeln ergaben, dass 
der Hauptanteil der von den Kortiko-
steronimmunoassays gemessenen 
Immunreaktivität nicht von Kortiko-
steron selbst, sondern von anderen 
Substanzen verursacht wurde. Im 
Eiklar konnte echtes Kortikosteron 
nicht nachgewiesen werden. Bei 
der Analyse von Bankivadotter wur-
den drei Gestagenspitzen mit Kon-
zentrationen von bis zu 2000 ng pro 
Fraktion entdeckt, während der 
Kortikosteronspitzenwert bei 0.8 ng 
pro Fraktion lag. Beide Kortiko-
steronimmunoassays fanden einen 
etwas höheren Kortikosteronwert 
im Dotter der mit dem Kortiko-
steronpellet implantierten Henne 
(EIA: 0.7 ng; RIA: 0.5 ng pro Frak-
tion) im Vergleich zum Kontrolltier 
(EIA: 0.5 ng; RIA: 0.2 ng pro Frak-
tion), aber beide Antikörper banden 
auch etliche andere Substanzen, 
höchstwahrscheinlich Gestagene. 
Schlussfolgerungen
Unsere Ergebnisse zeigen, dass 
obwohl ein geringer Teil von zirkulie-
rendem Kortikosteron in den Dotter 
überzutreten scheint, die direkte 
Messung von Kortikosteron im Vo-
gelei mittels Immunassays nicht an-
zuraten ist.
284
Wiener Tierärztliche Monatsschrift – Veterinary Medicine Austria 100 (2013)
 Introduction
Prior to ovulation, the avian follicle produces a variety 
of steroid hormones (ETCHES and DUKE, 1994), which 
partly accumulate in the yolk of the egg. Ample research 
has shown that these hormones in uence both physiolo-
gy and behaviour of the developing bird embryo. Mater-
nal steroid hormone deposition in eggs is therefore re-
garded as a mechanism to optimize reproductive 
success and hormone-mediated maternal effects have 
recently received considerable attention. Most studies 
focus on functional approaches, although the validity of 
the analytical methods applied has not yet been critically 
assessed. CEKAN (1979) de nes a ‘valid’ assay as the 
one that yields results identical to the true value within 
the limits of experimental error. The author also high-
lights the relevance of both the speci city of the antise-
rum and the ratio between the steroid of interest and 
impurities in the sample. If a cross-reacting substance is 
present in high concentrations, measurements can be 
confounded, despite a low level of cross-reactivity. The 
latter point is especially important when a previously un-
characterized matrix is analysed and it is important to 
assess which substances are actually measured by the 
method used (MÖSTL et al., 2005). When high-perfor-
mance liquid-chromatographic (HPLC) separations of 
chicken yolk extracts were analysed with a cortico-
sterone immunoassay, it was found that the corticoste-
rone antibody detects high amounts of immunoreactive 
substances that differ from authentic corticosterone
(RETTENBACHER et al., 2005). The authors concluded 
that the signal measured by the corticosterone immuno-
assay in homogenized yolk is not caused by cortico-
sterone itself. It was subsequently found that these
immunoreactive substances show the same chromato-
graphic characteristics as the gestagens progesterone 
and pregnenolone and the gestagen metabolites
5α- and 5β-pregnane-3,20-diones, all of which
cross-react with the corticosterone antibody used
(RETTENBACHER et al., 2009).
Compared to other gonadal steroids, gestagens are 
present at extremely high levels in the yolk, partly due 
to their lipophilic characteristics, but also because 
they are produced by the granulosa cells, which are 
closest to the yolk, whereas androgens and oestro-
gens are synthesized further away in the theca cell 
layer. Absolute levels differ slightly be-
tween studies due to differences in analytical me-
thods but progesterone concentrations of about
1000 ng/g yolk are generally reported (e.g. LIPAR et 
al., 1999; MÖSTL et al., 2001; BERTIN et al., 2008) 
and pregnenolone levels have been reported to be 
about 10-fold higher than those of progesterone
(HARTMANN et al., 1998). The absolute concentra-
tions of corticosterone are much lower than those of 
gestagens, probably because the glucocorticoid cor-
ticosterone is mainly produced in the adrenocortex 
and has to reach the oocyte via circulation. By means 
of gas chromatography-mass spectrometry (GC-MS), 
SAS et al. (2006) found corticosterone levels of bet-
ween 0.2 ng and 0.9 ng/g yolk. This illustrates that 
even a low cross-reactivity of about 0.1% of a cortico-
sterone antibody with e.g. progesterone would alrea-
dy result in an overestimation of the actual cortico-
sterone concentrations in yolk. This poses serious li-
mitations to the application of immunoassays for the 
quanti cation of corticosterone in yolk without pre-
vious clean-up and has frequently led to an overesti-
mation of actual yolk corticosterone levels. 
The situation in the albumen remains elusive, as 
analytical validations have not yet been performed. In 
contrast to the yolk, which accumulates during the 
maturation of the steroid-synthesising follicle, albu-
men is secreted in the oviduct and progesterone con-
centrations in the albumen are much lower than in 
yolk (MÖSTL et al., 2001). Quanti cation of cortico-
sterone in albumen might therefore be less confoun-
ded by cross-reacting compounds. To investigate this 
point we performed HPLC immunograms of chick-
en albumen samples and compared measurements 
of a progesterone and a corticosterone enzyme
immunoassay (EIA). Similarly, we conducted analyti-
cal validations for yolk of bankivas (Gallus gallus
bankiva). Bankiva or red jungle fowl is the ancestor of 
the domestic chicken (SAWAI, 2010) and in contrast 
to domestic chicken strains has not been subjected 
to arti cial selection for reproduction (ROMANOV et 
al., 1999). Its egg yolk might thus have a different hor-
mone composition. In addition, the impact of experi-
mentally elevated plasma corticosterone concentra-
tions on yolk corticosterone has not yet been 
addressed with the proper analytical methods in chick-
ens, as egg yolks analysed previously were collected 
from unstressed chickens (RETTENBACHER et al., 
2009). We therefore analysed yolks from hens with or 
without corticosterone-releasing implants. We also 
compared measurements made with the previously 
used in-house corticosterone antibody with those 
corticosterone. In albumen, the concentration of authen-
tic corticosterone was below the detection limit. Analysis 
of bankiva yolk revealed three major gestagen peaks with 
concentrations of up to 2000 ng per fraction and a corti-
costerone peak of about 0.8 ng per fraction. Both corti-
costerone assays found a slightly higher corticosterone 
peak in a corticosterone-implanted hen’s yolk (EIA:
0.7 ng; RIA: 0.5 ng per fraction) compared to the sham-
treated female (EIA: 0.5 ng; RIA: 0.2 ng per fraction) but 
both antibodies also bound to several other substances, 
presumably gestagens. Although a certain amount of cir-
culating corticosterone might pass into the yolk, direct 
quanti cation of corticosterone in non-homogenized
avian egg samples via immunoassays is not advisable.
Abbreviations: EIA = enzyme immunoassay; HPLC = high-
performance liquid-chromatography; RIA = radioimmuno-
assay 
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obtained with a commercially available RIA. The aim 
was to extend our knowledge about hormones in the 
yolk of a domestic species and to shed light on the 
situation in bird eggs in general.
 Material and methods
Animals and sample collection 
Eggs for the albumen analysis were obtained from a 
same-aged group of female Lohman brown laying 
hens that were kept in a free-range husbandry sys-
tem. Yolks of the same eggs were analysed in a pre-
vious study (RETTENBACHER et al., 2009). Eggs 
from bankiva chickens were obtained from the Uni-
versity of Groningen’s laboratory breeding popula-
tion. Female and male bankivas were housed pair 
wise in outdoor aviaries. Domestic chickens and
jungle fowl were not being used for experiment 
around the time eggs were collected.
Yolks of chickens with elevated concentrations of 
plasma corticosterone were obtained from an experi-
ment where chickens were implanted with cortico-
sterone-releasing pellets or placebo pellets (for details 
see HENRIKSEN et al., 2011a). Following implantation, 
concentrations of plasma corticosterone were
signi cantly elevated over a period of nine days. We 
used eggs that were yolked when the females’ plas-
ma corticosterone levels were maximally elevated for 
our analysis: Deposition of radiolabelled hormones
or substances such as Sudan dyes into the yolk of 
chickens occurs during the last eleven days of yolk 
formation (GRAU, 1976; GILBERT et al., 1983;
RETTENBACHER et al., 2005) and an additional
25-hour period is necessary for albumen and shell 
formation (WARREN and SCOTT, 1934). Therefore, 
authentic yolk corticosterone concentrations were 
analysed via HPLC immunograms of eggs from day 
14 after implantation: such eggs would have experi-
enced peak concentrations of circulating plasma cor-
ticosterone. 
Extraction of egg albumen
From each of six eggs, 10 ml of albumen were 
mixed with 10 ml of double-distilled water and 1 ml of 
saturated NaHCO3 and stirred for 30 min. Tritiated 
progesterone and corticosterone (all radiolabelled 
hormones from Perkin Elmer, MA, USA) were added 
as standards. 40 ml of methanol (100%) was added 
dropwise and the mixture was stirred for 30 min. After 
centrifugation, 30 ml of the supernatant was diluted 
with 45 ml of double-distilled water and loaded onto a 
primed Sep-Pak® C18 cartridge (Waters) via air ow. 
Cartridges were washed with 10 ml each of double-
distilled water and methanol (30%) and left to dry 
overnight. Elution was performed the following day 
with 5 ml methanol (100%). Samples were dried
under nitrogen  ow, suspended in 0.1 ml of
n-hexane:chloroform (70:30) and injected onto the 
HPLC column (for chromatographic conditions see 
below). 
Extraction of yolk
Yolks of two bankiva eggs were homogenized and
5 g of each yolk sample was mixed with 10 ml of
double-distilled water and stirred for 30 min. For the 
chicken yolks, two eggs laid on day 14 after implanta-
tion were analysed. One egg was collected from a 
female that had been implanted with a cortico-
sterone-releasing pellet (cort chicken), the other from 
a placebo pellet-implanted chicken (placebo chicken). 
For recoveries and standards, radiolabelled corticos-
terone was added to all yolk samples and
radiolabelled pregnenolone was added to the bankiva 
yolk samples. After drop wise addition of 30 ml
methanol, samples were stirred for 30 min. After
centrifugation, supernatants were processed as
described above for the albumen. Straight-phase 
HPLC separations were performed under room-
temperature with a LiChrosorb® Si 60 (10 µm)- lled 
column (Forschungszentrum Seibersdorf, Austria) 
using a mixture of n-hexane:chloroform (70:30) as 
eluate and a linear methanol gradient from 0–6% me-
thanol. The  ow was 2 ml per min and 76 fractions 
were collected at 30 s intervals. The eluate was eva-
porated and samples were reconstituted in assay 
buffer. Aliquots of the fractions were used to
determine radioactivity via liquid scintillation counting 
(Packard Tri-Carb 2100TR, Meriden, CT).
Immunoassays
In the chicken albumen and bankiva yolk extracts, 
concentrations of immunoreactive corticosterone 
and progesterone were determined using antibodies 
against corticosterone (PALME and MÖSTL, 1997) 
and 5β-pregnane-3α-ol-20-one (SCHWARZENBERGER 
et al., 1996) as described previously (RETTENBACHER 
et al., 2009). The yolk samples of the pellet-implanted 
chickens were also analysed with a commercial RIA 
(MP Biomedicals, Costa Mesa, CA) as described by 
GOERLICH et al. (2010). 
 Results
The elution positions of the radiolabelled standards 
differ between the individual chromatograms, which 
we attribute to the fact that HPLC separation was 
performed at room temperature. Nevertheless, a re-
liable separation of corticosterone from cross-reac-
ting gestagens was achieved in all runs. The elution 
positions of the radiolabelled standards in the
albumen analysis were fraction 16 for progesterone 
and fraction 35 for corticosterone. In the bankiva yolk 
analysis, the pregnenolone standard eluted in fraction 
15 and the corticosterone standard in fraction 28, while 
fraction 32 was established for the corticosterone
286
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standard in the chicken yolk analysis. The exact elution 
positions of gestagens were not assessed in the
chicken yolk HPLCs. Mean (±s.d.) recovery of the radio-
labelled tracers was 87±13% for progesterone and 
87±9% for corticosterone. The recovery of radiolabelled 
pregnenolone (used only for bankiva yolks) was not as-
sessed. The detection limits of the enzyme immunoas-
says were 0.4 ng per fraction for progesterone and
0.01 ng per fraction for corticosterone in albumen. In the 
yolks, the detection limit for corticosterone was
0.01 ng/G both for the EIA and for the RIA. For practical 
reasons, chicken yolk extracts were analysed several 
weeks after the analysis of albumen and bankiva yolk 
extracts, but HPLC separation of corticosterone and 
placebo pellet-implanted chicken yolk extracts was 
performed on the same day and under the same condi-
tions.
Albumen 
In the albumen, concentrations of immunoreactive 
metabolites measured by the corticosterone EIA did 
not exceed 0.8 ng in any fraction. Two large peaks of 
about 0.8 ng were detected in fractions 12 and 16, with 
the second peak co-eluting with the progesterone 
standard. A third smaller peak was found around frac-
tion 20. No peaks were visible at the elution position of 
corticosterone (fraction 35) and concentrations were 
below 0.07 ng in all other fractions. In the progesterone 
EIA, immunoreactive peaks were detected in exactly 
the same fractions as in the corticosterone EIA but in 
this case the two peaks in fractions 12 and 16 were not 
of the same height: the  rst peak was around 18 ng per 
fraction and the second peak, co-eluting with the pro-
gesterone standard, was only about 4 ng per fraction. 
Concentrations were below 1 ng in all other fractions 
(see Fig. 1a).
Yolk of bankiva 
In the HPLC separations of the bankiva yolk
extracts, the corticosterone EIA detected three peaks 
around fractions 7, 10 and 15 with concentrations of 
about 1.2 ng to 2 ng per fraction. The third peak
co-eluted with the pregnenolone standard. A much 
smaller peak of about 0.3 ng eluted in fraction 20. At 
the elution position of authentic corticosterone, a 
peak of about 0.8 ng per fraction was detected. In all 
other fractions, immunoreactivity was below 0.3 ng 
per fraction. The progesterone EIA detected immuno-
reactive peaks in the same fractions but concentra-
tions declined from  rst to second and third peak, 
ranging from 1700 ng in fraction 7 to 310 ng in fraction 
10 and 170 ng in fraction 15, respectively (see Fig. 1b). 
Pellet-implanted chicken
In the yolk of the corticosterone pellet-implanted 
chicken, the corticosterone EIA detected one peak 
of about 1.7 ng in fraction 7. Between fractions 13 
and 17, several immunoreactive substances eluted 
as one large second peak with concentrations of 
between 1 and 2 ng per fraction. An immunoreactive 
peak of about 0.7 ng per fraction was observed at 
the elution position of corticosterone. In all other 
fractions, concentrations were below 0.08 ng. When 
the same fractions were analysed with the cortico-
sterone RIA, six individual peaks between fractions 
7 and 25 could be distinguished, with concentra-
tions ranging from 0.8 ng to 0.2 ng per fraction. A 
corticosterone peak of about 0.5 ng was found in 
fraction 32. In addition a very small peak around 
fraction 38 was visible, which was not observed in 
the EIA analysis (see Figure 2a). In the placebo chicken 
yolk, the corticosterone EIA detected three major 
non-polar peaks in fractions 8, 12 and 17 of about 
2.2 ng, 3 ng and 1.6 ng per fraction, respectively. A 
peak at the elution position of corticosterone of 0.5 ng 
per fraction was also observed. The corticosterone 
RIA detected  ve or more immunoreactive substan-
ces in fractions 8 to 23 with concentrations ranging 
from 0.6 ng to 0.4 ng and a peak of about 0.2 ng per 
fraction at the elution position of corticosterone. 
Again, substances with higher polarity that had a 
longer retention time than corticosterone eluting 
around fraction 38 were detected by the cortico-
sterone RIA but not by the EIA (see Fig. 2b).
 Discussion
Quanti cation of corticosterone in eggs has been 
used as a non-invasive method to quantify stress 
as well as to assess the impact of maternal stress 
on offspring. However, analytical validations should
always be performed before embarking on the ana-
lysis of a previously uncharacterized matrix. The 
crucial aspect is a thorough evaluation of what is 
picked up by the antibody used and whether the 
resulting measurement truly re ects the substance 
of interest at biologically relevant concentrations. 
To test a newly developed antibody, CEKAN (1979) 
coined the term ‘assay validity’. To assess which 
substance in a sample is actually measured, the 
term ‘analytical validation’ has evolved in relation 
to non-invasive monitoring of hormones in excreta 
(MÖSTL et al., 2005; TOUMA and PALME, 2005). In 
this approach, samples are  rst subjected to chro-
matographic puri cation and the collected frac-
tions are measured by means of the immunoassays 
in question. In this manner, RETTENBACHER et al. 
(2009) revealed that chicken egg yolk contains high 
concentrations of gestagens and gestagen meta-
bolites that give rise to a signal in a corticosterone 
enzyme immunoassay. Due to the vast differences 
in absolute concentrations between gestagens and 
corticosterone, quanti cation of corticosterone via 
immunoassays in chicken yolk is hampered, even 
when cross-reactivities with e.g. progesterone 
seem small.
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This result related to the analysis of yolks of un-
stressed chickens only, using a single in-house corti-
costerone antibody (RETTENBACHER et al., 2009). 
We have now assessed whether corticosterone can 
be reliably measured in albumen, which contains
lower levels of gestagens than yolk. Furthermore, yolk 
extracts of a hen with experimentally elevated plasma 
corticosterone levels and a sham-treated female were 
analysed to assess the impact of elevated plasma 
corticosterone concentrations on the measurement 
of authentic yolk corticosterone. Furthermore, the 
corticosterone EIA previously used was compared to 
a commercial RIA kit. We found that, substances 
other than authentic corticosterone caused signals in 
the corticosterone immunoassays in all samples
analysed. This was the case for both yolk and
albumen and for arti cially stressed chickens and 
non-domestic birds. In every immunogram perfor-
med, at least four individual peaks were visible when
individual fractions were measured by immunoassay.
Similarly to  ndings by MÖSTL et al. (2001) and
RETTENBACHER et al. (2009), three major peaks 
were seen in analyses of chicken albumen and
bankiva yolk. Absolute concentrations differed
greatly between albumen and yolk, in line with pre-
vious observations (MÖSTL et al., 2001; JANCZAK et al., 
Fig. 1a: High-performance liquid chromatographic separations of chicken albumen. Immunoreactivity was measured with a cortico-
sterone enzyme immunoassay (solid line) and a progesterone enzyme immunoassay (stippled line). Elution positions of the stan-
dards are indicated by arrows.
Fig. 2a: High-performance liquid chromatographic separations of yolk from a chicken implanted with a corticosterone-releasing pellet.
Immunoreactivity was measured with a corticosterone enzyme immunoassay (solid line) and a corticosterone radio immunoassay
(stippled line). Elution position of the corticosterone standard is indicated by an arrow.
Fig. 1b: High-performance liquid chromatographic separations of bankiva yolk. Immunoreactvity was measured with a corticosterone 
enzyme immunoassay (solid line) and a progesterone enzyme immunoassay (stippled line). Elution positions of the standards are indi-
cated by arrows.
Fig. 2b: High-performance liquid chromatographic separations of yolk from a chicken implanted with a placebo pellet. Immunoreactivity 
was measured with a corticosterone enzyme immunoassay (solid line) and a corticosterone radio immunoassay (stippled line). Elution 
position of the corticosterone standard is indicated by an arrow.
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2009), but both in albumen and in yolk the  rst peak 
was predominant and had a different chromatographic 
mobility from that of the standards. The second peak 
co-eluted with progesterone and the third peak with 
pregnenolone. RETTENBACHER et al. (2009) sugges-
ted that highly apolar substances such as 5α- and 
5β-reduced compounds (5α-and 5β-pregnane-3,20-
dione) are present in yolk. Follicle cells are capable of 
synthesizing a plethora of steroids (WIEBE et al., 1990), 
so it is conceivable that several unidenti ed gestagen 
and their metabolites are present in the yolk. In the 
HPLC immunograms, each peak represents at least 
one immunoreactive substance but it is also possible 
that two or more substances with similar chromatogra-
phic characteristics elute as one larger peak. The ob-
servation that the  rst peak showed the highest
immunoreactivity does not imply that the correspon-
ding substance is present at the highest concen-
trations in the yolk: the peak might result from two
different compounds that elute in the same fractions.
It is also likely that the progesterone antibody used 
has a higher af nity for e.g. 5β-pregnanes than for 
pregnenolone. It should be noted that exhaustive 
identi cation of the cross-reacting substances was 
not the main aim of the present study, which was 
undertaken to assess whether they bind to cortico-
sterone antibodies. The corticosterone assay and 
the progesterone assay detected peaks in exactly 
the same fractions, both in chicken albumen and in 
bankiva yolk, suggesting that the antibodies in both 
EIAs bind to the same steroids. Furthermore, we 
analysed HPLC separations of the pellet and place-
bo-implanted hens’ yolks with two different immu-
noassays. Both tests indicated the presence of se-
veral cross-reacting compounds. Compared to the 
EIA, the RIA detected a number of additional peaks 
and also measured immunoreactive substances 
with a higher polarity than corticosterone. The dif-
ferences between the patterns found with the RIA 
and the EIA again suggest that individual fractions 
contain several metabolites with different af nities 
to the two antibodies. The two antibodies were 
raised against the same immunogen (cortico-
sterone-3-CMO) but slight differences were visible 
in the two immunograms. Previous comparison of 
another commercial antibody to the in-house anti-
body gave similar results, although the percentages 
of cross-reactivities with progesterone differ greatly 
between the three antibodies (1.4% in the EIA and 
0.02% in the RIA used in the present study; 15% in 
the RIA used by QUILLFELDT et al., 2011). This
underlines that in addition to knowing the speci city 
of an antibody (i.e. its cross-reactions with particular 
steroids) it is necessary to assess which substances 
are present in the matrix to be analysed and whether 
they cross-react with the antibody used.
To date, all corticosterone immunoassays tested 
have largely measured immunoreactive substances 
with chromatographic characteristics different from 
authentic corticosterone (QUILLFELDT et al., 2011; 
this study). From these results it seems highly likely 
that all antibodies raised against corticosterone
coupled on position three will cross-react with yolk 
gestagens and are thus not suitable for the quanti -
cation of corticosterone in egg yolk. It is therefore not 
advisable to perform corticosterone quanti cation in 
yolk by means of immunoassays, even when cross-
reactivities seem small. The present study found cor-
ticosterone levels in the albumen to be below the de-
tection limit, which  ts with the observation that 
overall hormone concentrations are much lower in 
albumen than in yolk (see above). It is still unclear 
whether steroids diffuse from the lipophilic yolk into 
the albumen after the egg is produced or are transfer-
red from the plasma into the albumen later in the for-
mation of the egg, probably during albumen secretion 
in the oviduct. Further studies should use more sensi-
tive methods to evaluate whether plasma cortico-
sterone concentrations are re ected in the albumen. 
We did not analyse albumen from hens with experi-
mentally elevated plasma corticosterone levels in the 
present study. Given the small increase of authentic 
corticosterone in the yolk after pellet implantation, we 
think it unlikely that there will be detectable concen-
trations of corticosterone in albumen.
Steroid hormones in the blood reach the oocyte du-
ring yolk formation (ARCOS 1972; HACKL et al., 2003; 
RETTENBACHER et al., 2005) and it is conceivable 
that a share of circulating corticosterone is transferred 
from the plasma into the yolk. From the few studies on 
the topic that rigorously excluded cross-reacting com-
pounds it could be inferred that corticosterone is 
transferred from plasma into the yolk in a dosage-de-
pendent manner: In the present study, yolks from
chickens with plasma corticosterone levels elevated 
within the physiological range were analysed and a 
slightly higher corticosterone peak was detected in the 
yolk of the corticosterone-pellet implanted chicken 
(EIA: 0.7 ng; RIA: 0.5 ng per fraction) than in the place-
bo-treated control (EIA: 0.5 ng; RIA: 0.2 ng per frac-
tion). Eggs for the present analysis were collected from 
laying hens implanted with pellets designed for a con-
tinuous release of 30 mg corticosterone over 60 days 
(HENRIKSEN et al., 2011a). Although the yolks were 
produced while plasma corticosterone levels were sig-
ni cantly elevated, the observed difference in yolk cor-
ticosterone concentrations between pellet and place-
bo-implanted animals was rather small. Studies where 
plasma corticosterone concentrations were conside-
rably elevated above physiological levels clearly show 
that a certain share of corticosterone passes from the 
circulation into the yolk during egg formation. Transfer 
of corticosterone into egg yolk was observed after fee-
ding 0.1 g of crystallized corticosterone to laying hens 
(RETTENBACHER et al., 2005) and, after implantation 
of barn owls with corticosterone-releasing pellets,
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authentic corticosterone concentrations of about
5 ng were found in their yolks (ALMASI et al., 2012), 
whereas a single injection of ACTH in chickens was not 
re ected in elevated yolk corticosterone concentra-
tions (RETTENBACHER et al., 2005). These data indi-
cate that transfer of plasma corticosterone into egg 
yolk depends on the extent of the arti cial elevation of 
plasma corticosterone. Whether a natural stressor also 
elevates yolk corticosterone levels has not been evalu-
ated with appropriate analytical methods. Neverthe-
less, the work cited above shows that endogenous 
corticosterone can pass into the yolk if it is present in 
the plasma in high concentrations and/or elevated over 
a prolonged time span. 
A peak of 0.8 ng corticosterone was detected in 
bankiva yolk. As the corticosterone levels in bankiva 
plasma were not assessed in the present study, we 
do not know whether the yolks were produced under 
stressful conditions or whether baseline glucocorti-
coid levels are higher than in the domestic chickens. 
Unfortunately, the few studies that used the proper 
analytical methods to measure yolk corticosterone 
levels in birds with unmanipulated plasma cortico-
sterone levels do not report plasma corticosterone 
concentrations. We can thus only speculate on the 
levels of circulating corticosterone levels in these fe-
males. In yolks of caged and free-ranged hens, SAS 
et al. (2006) found corticosterone concentrations bet-
ween 0.2 ng and 0.9 ng/g. In bankiva yolk, a distinct 
corticosterone peak of about 0.8 ng was visible (this 
study). Our analyses of placebo pellet implanted chi-
ckens with two immunoassays revealed the presence 
of peaks of about 0.5 ng and 0.2 ng in the yolk,
whereas previous studies reported authentic cortico-
sterone peaks of about 0.7 ng only in the inner regi-
ons of the yolk (RETTENBACHER et al., 2009) or un-
detectable levels of corticosterone in the yolk 
(RETTENBACHER et al., 2005). Similar observations 
were made in southern rockhopper penguins and im-
perial shags: in both species some yolks were found 
to contain corticosterone whereas others did not 
(QUILLFELDT et al., 2011). This indicates that the
corticosterone content of individual eggs might differ 
and enhances the need for further investigations.
Concluding remarks
From the present  ndings we conclude that the 
yolks of bird species other than domestic chicken 
also contain a number of cross-reacting substances 
that hamper quanti cation of authentic cortico-
sterone, which is itself present in the yolk only in
minimal amounts. The same situation was observed 
in chicken albumen, where authentic corticosterone 
was not found in detectable amounts. Although arti-
 cial elevation of plasma corticosterone concentra-
tions over a longer period seems to increase concen-
trations of corticosterone in the yolk, direct 
quanti cation in the unhomogenized yolk is not
advisable. The literature is littered with studies that 
have overestimated the actual yolk corticosterone 
concentrations due to analytical  aws of this kind. As 
a result, there is a misplaced con dence that amounts 
of yolk corticosterone accurately re ect changes in
circulating concentrations.
It has been postulated that transferred maternal 
corticosterone acts as a signal for the developing em-
bryo (HENRIKSEN et al., 2011b). However, it is impor-
tant to consider the impact of local glucocorticoid 
metabolism. A recent in vitro study showed that
chicken follicle cells metabolize corticosterone
(RETTENBACHER et al., 2013), probably by means of 
enzymes such as 11β-HSD and 20β-HSD that have 
been found in the chicken ovary (KLUSONOVA et al., 
2008). Whether degradation is performed solely to 
avoid local glucocorticoid overexposure in the
ovarian tissue or might also have a protective function 
for the chicken embryo remains to be clari ed.
Furthermore, the biological relevance of the transfer-
red concentrations for the developing embryo might 
be disputed. Besides ovarian corticosterone meta-
bolism (RETTENBACHER et al., 2013), embryonic
tissues also contain enzymes that degrade cortico-
sterone (VON ENGELHARD et al., 2009), suggesting 
that the developing bird has some control over the 
amount of maternal corticosterone to which it is ex-
posed. Although the time course of embryonic yolk 
consumption is not fully elucidated, it is unlikely that 
the entire amount of corticosterone is incorporated 
before the onset of endogenous glucocorticoid pro-
duction around day eight of incubation (JENKINS and 
PORTER, 2004). It is therefore highly questionable 
whether the low concentrations of yolk cortico-
sterone have any biological relevance for the develo-
ping embryo. The role of corticosterone as a mediator 
of transgenerational stress in birds should thus be 
critically evaluated. Alternative pathways by which
mothers might signal stressful conditions to their off-
spring have recently been elucidated. Elevated 
plasma corticosterone affects egg composition as 
well as concentrations of reproductive hormones in 
the yolk (HENRIKSEN et al., 2011a). Parameters such 
as yolk testosterone levels or egg weight might serve 
as an indirect but more appropriate measure of
maternal stress. 
Acknowledgements
The authors would like to thank Amanda Aichinger for 
technical assistance and Alexandra Kuchar for per-
forming the HPLC separations. The RIA analyses 
were performed in the lab of Ton Groothuis in Gronin-
gen. The support of the Austrian Science Foundation 
(FWF Proj. Nr. 19169-B17) is gratefully acknowledged. 
We also thank Rupert Palme for initiating and orga-
nizing the conference on non-invasive monitoring of 
hormones together with the team of the ISWE and the 
editors of this special issue.
290
Wiener Tierärztliche Monatsschrift – Veterinary Medicine Austria 100 (2013)
 References
ALMASI, B., RETTENBACHER, S., MÜLLER, C., BRILL, S., 
WAGNER, H., JENNI, L. (2012): Maternal corticosterone 
is transferred into the egg yolk. Gen Comp Endocrinol 
178, 139–144.
ARCOS, M. (1972): Steroids in egg-yolk. Steroids 19, 25–34.
BERTIN, A., RICHARD-YRIS, M.A., HOUDELIER, C.,
LUMINEAU, S., MÖSTL, E., KUCHAR, A., HIRSCHENHAUSER, 
K., KOTRSCHAL, K. (2008): Habituation to humans af-
fects yolk steroid levels and offspring phenotype in quail. 
Horm Behav 54, 396–402.
CEKAN, S.Z. (1979): On the assessment of validity of steroid 
radioimmunoassays. J Steroid Biochem 11, 1629–1634.
ETCHES, R.J., DUKE, C.E. (1984): Progesterone, androstene-
dione and oestradiol content of theca and granulosa tissues 
of the four largest ovarian follicles during the ovulatory cycle 
of the hen (Gallus domesticus). J Endocrinol 103, 71–76.
GOERLICH, V.C., DIJKSTRA, C., BOONEKAMP, J.J., 
GROOTHUIS, T.G. (2010): Change in body mass can 
overrule the effects of maternal testosterone on prima-
ry offspring sex ratio of  rst eggs in homing pigeons.
Physiol Biochem Zool 83, 490–500. 
GRAU, C.R. (1976): Ring structure of avian egg-yolk. Poult 
Sci 55, 1418–1422.
HACKL, R., BROMUNDT, V., DAISLEY, J., KOTRSCHAL, 
K., MÖSTL, E. (2003): Distribution and origin of steroid 
hormones in the yolk of Japanese quail eggs (Coturnix 
coturnix japonica). J Comp Physiol B 173, 327–331.
HARTMANN, S., HARTMANN, S., LACORN, M., STEINHART, 
H. (1998): Natural occurrence of steroid hormones in 
food. Food Chem 62, 7–20.
HENRIKSEN, R., GROOTHUIS, T.G., RETTENBACHER, 
S. (2011a): Elevated plasma corticosterone decreases 
yolk testosterone and progesterone in chickens: linking
maternal stress and hormone-mediated maternal ef-
fects. PLoS One 6, e23824.
HENRIKSEN, R., RETTENBACHER, S., GROOTHUIS, T.G. 
(2011b): Prenatal stress in birds: pathways, effects, function 
and perspectives. Neurosci Biobehav Rev 35, 1484–1501.
JANCZAK, A.M., TORJESEN, P., RETTENBACHER, S. (2009): 
Environmental effects on steroid hormone concentrations 
in laying hens‘ eggs. Acta Agric Scand A 59, 80–84.
JENKINS, S.A., PORTER, T.E. (2004): Ontogeny of the hy-
pothalamo-pituitary-adrenocortical axis in the chicken 
embryo: A review. Domest Anim Endocrinol 26, 267–275.
KLUSONOVA, P., KUCKA, M., ERGANG, P., MIKSIK, I., 
BRYNDOVA, J., PACHA, J. (2008): Cloning of chicken 
11β-hydroxysteroid dehydrogenase type 1 and its tissue 
distribution. J Steroid Biochem Mol Biol 111, 217–224.
LIPAR, J.L., KETTERSON, E.D., NOLAN, V. JR., CASTO, 
J.M. (1999): Egg yolk layers vary in the concentration of 
steroid hormones in two avian species. Gen Comp Endo-
crinol 115, 220–227.
MÖSTL, E., SPENDIER, H., KOTRSCHAL, K. (2001): Concen-
tration of immunoreactive progesterone and androgens in 
the yolk of hens‘ eggs (Gallus domesticus). Wien Tierärztl 
Monat – Vet Med Austria 88, 62–65. 
MÖSTL, E., RETTENBACHER, S., PALME, R. (2005): Meas-
urement of corticosterone metabolites in birds‘ droppings: 
an analytical approach. Ann NY Acad Sci 1046, 17–34. 
PALME, R., MÖSTL, E. (1997): Measurement of cortisol meta-
bolites in faeces of sheep as a parameter of cortisol concen-
tration in blood. Z Säuget-Int J Mammal Biol 62, 192–197. 
QUILLFELDT, P., POISBLEAU, M., PARENTEAU, C., TROUVE, 
C., DEMONGIN, L., VAN NOORDWIJK, H.J., MÖSTL, E. 
(2011): Measuring corticosterone in seabird egg yolk and 
the presence of high yolk gestagen concentrations. Gen 
Comp Endocrinol 173, 11–14. 
RETTENBACHER, S., MÖSTL, E., HACKL, R., PALME, R. 
(2005): Corticosterone in chicken eggs. Ann NY Acad Sci 
1046, 193–203. 
RETTENBACHER, S., MÖSTL, E., GROOTHUIS, T.G.G. 
(2009): Gestagens and glucocorticoids in chicken eggs. 
Gen Comp Endocrinol 164, 125–129. 
RETTENBACHER, S., HENRIKSEN, R., GROOTHUIS, T.G.G., 
LEPSCHY, M. (2013): Corticosterone metabolism by chicken 
follicle cells does not affect ovarian reproductive hor-
mone synthesis in vitro. Gen Comp Endocrinol 184, 67–74.
ROMANOV, M.N., TALBOT, R.T., WILSON, P.W., SHARP, 
P.J. (1999): Inheritance of broodiness in the domestic 
fowl. Br Poult Sci 40 (Suppl), S20–S21. 
SAS, B., DOMANY, G., GYIMOTHY, I., KOVACSNE, K.G., 
SUTH, M. (2006): In uence of the type of management 
system on corticosterone transfer into eggs in laying 
hens. Acta Vet Hung 54, 343–352. 
SAWAI, H., KIM, H.L., KUNO, K., SUZUKI, S., GOTOH, H., 
TAKADA, M., TAKAHATA, N., SATTA, Y., AKISHINONOMIYA, 
F. (2010): The origin and genetic variation of domestic 
chickens with special reference to junglefowls Gallus g 
gallus and G varius. PLoS One 5, e10639.
SCHWARZENBERGER, F., TOMASOVA, K., HOLECKOVA, 
D., MATERN, B., MÖSTL, E. (1996): Measurement of fecal 
steroids in the black rhinoceros (Diceros bicornis) using 
group-speci c enzyme immunoassays for 20-oxo-preg-
nanes. Zoo Biol 15, 159–171. 
TOUMA, C., PALME, R. (2005): Measuring fecal glucocorti-
coid metabolites in mammals and birds: the importance 
of validation. Ann NY Acad Sci 1046, 54–74. 
VON ENGELHARDT, N., HENRIKSEN, R., GROOTHUIS, 
T.G. (2009): Steroids in chicken egg yolk: metabolism and 
uptake during early embryonic development. Gen Comp 
Endocrinol 163, 175–183. 
WARREN, D.C., SCOTT, H.M. (1934): Ovulation in the do-
mestic hen. Science 80, 461–462. 
WIEBE, J.P., BUCKINGHAM, K.D., ZOBELL, R.L., HERTELENDY, 
F. (1990): Metabolism of progesterone by avian granulosa-
cells in culture. J Steroid Biochem Mol Biol 37, 113–120. 
*corresponding author´s address:
Sophie Rettenbacher, 
University of Veterinary Medicine Vienna,
Veterinärplatz 1, 1210 Vienna, Austria 
e-mail: sophie.rettenbacher@vetmeduni.ac.at
